House Bill 349
117th Congress(2021-2022)
Coronavirus Vaccine and Therapeutic Development Act of 2021
Introduced
Introduced in House on Jan 19, 2021
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
349
Congress
117
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No House votes have been held for this bill.
Summary
Coronavirus Vaccine and Therapeutic Development Act of 2021
This bill directs the Department of Health and Human Services (HHS) to increase the supply of vaccines and medical products that prevent or control COVID-19 (i.e., coronavirus disease 2019). To increase supplies, HHS must, as appropriate, award grants and enter other transactions to expand relevant research, procurement, and production activities.
HHS must report to Congress on these actions. The report must assess and detail plans to enhance the supply chain and manufacturing capacity for the vaccines and products. It must also include plans to support domestic and international vaccination programs.
January 19, 2021
02/05/2021
Sponsor introductory remarks on measure. (CR H393)
02/02/2021
Referred to the Subcommittee on Health.
01/19/2021
Referred to the House Committee on Energy and Commerce.
01/19/2021
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:43:34 PM